A living library of credible information for patients of multiple myeloma and their caregivers.
…
continue reading
Multiple Myeloma Podcasts
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
The International Myeloma Foundation (IMF) is the world’s first and largest myeloma organization, reaching more than 525,000 members in 140 countries. Founded in 1990, the IMF is a non-profit organization dedicated to improving the quality of life of myeloma patients and their families. The IMF funds research, provides education, lends support, and promotes advocacy initiatives that allow collective voices to be heard. The IMF’s dedicated and diverse staff provides immediate help. Our knowle ...
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
Emergency Medicine Cases – Where the Experts Keep You in the Know. For show notes, quizzes, videos and more learning tools please visit emergencymedicinecases.com
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
51
ClinicalXchange Oncology podcasts
Clinical Care Solutions, CCS ClinicalXchange Oncology Podcast
3
4
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Sit back and listen to Ulf-Henrik Mellqvist talking about the significant developments in the field of multiple myeloma treatment. What do the new possibilities mean for patients and doctors? And why should young doctors looking to specialize go into hematology?
…
continue reading
In these EHA-produced podcasts, experts share with you their hematology knowledge and stories. With "EHA Unplugged" we would like to give you the opportunity to unplug from your computer screen, while still learning, by listening to interviews, clinical cases, monologues, and more.
…
continue reading
Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
Editors at eClinicalMedicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from maternal health in the perinatal period and beyond to access to cancer care for people experiencing homelessness, the impact of weight bias in health care to oral treatments for MRSA skin infections, and more.
…
continue reading
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematolog ...
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
Hip. Hope. Hooray! Men Talkin’ Health was born out of my own journey—as a Black man navigating life with cancer. This show comes from a place of lived experience, healing, and the urgency to empower. I’ve been there... and now I’m bringing the mic to the movement. Men from underrepresented communities carry a heavy burden when it comes to health. Black Americans, for instance, have the highest mortality rates for most cancers, face delayed diagnoses, and lead in heart disease, diabetes, and ...
…
continue reading
As peer-to-peer fundraising professionals, we are inherently passionate people. Passionate about our missions, our fundraisers, our events, and our campaigns. We barely shy away from sharing our opinions. Whether it's the debate between back-to-basics, or searching for the next big idea, the battle of retention versus recruitment, or even our very strong feelings about T-shirts and registration fees. Welcome to The P2P box, a brand new podcast that amplifies the voices of our peer-to-peer fu ...
…
continue reading
In The Hematology Podcast, we dig into the clinical, the theoretical, and the practical, as we discuss the past, present, and future of the hematological field. MAT-DK-2100201(1.0) March 2021
…
continue reading
Medical oncologist Dr Neil Love interviews oncology experts. Free NCPD credit hours are available.
…
continue reading
Physicians' Education Resource® (PER®) is committed to advancing patient care through professional education. This podcast is a natural extension of PER®'s efforts to provide medical education for health care providers to stay up to date with advances in medical care, from diagnosis through treatment, with the ultimate goal of improving patient outcomes. Visit www.gotoper.com for more information.
…
continue reading
1
Physicians Practice Pearls: Physician News on Business, Healthcare, Medicine, and Technology
Podcast by Physicians Practice
33
Podcast by Podcast by Physicians Practice
…
continue reading
Welcome to the mibo show, where we focus on mind and body wellness… let’s talk about it!!! Each episode our guests will talk about their mental and/or physical health journey or that of their family. We will also have subject matter experts talk health facts and stats, best practices for wellness, and provide strategies to encourage us all how to live a healthy lifestyle where we prioritize our mind and body wellness on a regular basis!
…
continue reading
Wait How Do You Spell That? is a rare disease podcast produced by Patient Worthy. We talk about issues affecting people rare and underdiagnosed conditions and interview advocates from across the community. We‘re definitely not doctors, and we can‘t give you medical advice. We‘re just here to chat and learn about the diseases that even doctors can‘t seem to spell. Check out the latest in rare disease news at PatientWorthy.com.
…
continue reading
The Cancer Revolution podcast series looks to explore all areas of integrative, traditional and alternative means of beating cancer and creating sustained good health, for the young folks and old. Our topics will include areas such as immune system, metabolic theory, epigenetic, microbial connections, diet, mitigating side effects of cancer treatments, detoxification methods, anticancer nutrition, the latest news and stories in institutional cancer research
…
continue reading
Bringing you untold stories behind luminaries and legends of the New York City’s running culture. A new show from the CITIUS MAG Podcast Network. Hosted by Leigh Anne Sharek and Chris Chavez. Support us on Patreon: https://patreon.com/runnersofnyc Be sure to check out CITIUSMAG.com for all your latest running commentary. Support the show and rep Runners of NYC: https://www.bonfire.com/runners-of-nyc-podcast/ ▶ Follow us: twitter.com/RunnersOfNYC | Instagram.com/RunnersOfNYC | Facebook.com/Ci ...
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
1
Cancer Healing Journeys by ZenOnco.io & Love Heals Cancer
Kishan Shah, Vasundhara Raghavan, Nadia Raju, Prabhat Kumar Verma, Imran Shaikh, Vijay Sharnangat, Premitha R, Shreshtha Mittal, Divya Sharma, Bhumi Ben, Divya Par, Farida Rizwan, Asmita Bhattacharya, Sidharth Ghosh
2566
"In life, winning and losing will both happen. What is never acceptable is quitting." When you feel that you are alone in this journey, you really are not alone. There are countless warriors who have gone through a similar journey like what you are going through today; they have felt the immense pain that you are experiencing; but in the end, they have healed themselves from cancer. Some talk about their own journey as you are listening to this, while some have defeated pain forever, but in ...
…
continue reading
1
Rethinking Your Approach To Capacity Building with the Multiple Myeloma Research Foundation’s Diana Perrault
41:43
41:43
Play later
Play later
Lists
Like
Liked
41:43
Many fundraising teams are stretched thin, yet the work keeps expanding. Instead of pushing harder, some organizations are stepping back and reimagining what healthy capacity really looks like. When leaders center people, clarity and collaboration, teams gain the space they need to grow with purpose. In this episode, Marcie Maxwell talks with Diana…
…
continue reading
1
S1 Ep190: Evolutions Across NSCLC, Multiple Myeloma, and AML at Georgia Cancer Center
13:07
13:07
Play later
Play later
Lists
Like
Liked
13:07
As part of a visit to Georgia Cancer Center in Augusta, Georgia, CancerNetwork spoke with a variety of experts and faculty members regarding ongoing research and future initiatives dedicated to improving outcomes across different patient populations. These conversations touched upon potential developments in diseases including non–small cell lung c…
…
continue reading
1
A Multiple Myeloma and MRD Pioneer: EHA 2025 Lifetime Achievement Award (Prof Jesús San-Miguel)
26:39
26:39
Play later
Play later
Lists
Like
Liked
26:39
Join us for this inspiring interview with prof. Jesús San-Miguel from Clínica Universidad de Navarra in Spain who discusses his extensive work to improve care for patients with multiple myeloma. Prof San-Miguel’s research and clinical contributions have shaped the current treatment landscape for multiple myeloma. For his contributions, he has recei…
…
continue reading
1
The Role of Comorbidities in Treatment Decision-Making across the Spectrum of Prostate Cancer: A Podcast
31:27
31:27
Play later
Play later
Lists
Like
Liked
31:27
Managing prostate cancer today means balancing cancer control with overall health and wellbeing. This episode explores how chronic conditions, frailty, and quality-of-life considerations shape treatment choices from localised to advanced disease. Authors discuss why survival data has shifted the rationale for radical interventions, the complexities…
…
continue reading
1
Special Episode: Maternal Health in Hematology
20:47
20:47
Play later
Play later
Lists
Like
Liked
20:47
In this special episode, Blood editor Dr. Laura Michaelis interviews Dr. Arielle Langer and Blood Associate editor Dr. Marc Blondon for this special Maternal Health episode. In honor of the second Maternal Health compendium, both discuss their papers featured in this special collection. Featured Articles: β-Thalassemia minor is associated with high…
…
continue reading
1
Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
52:03
52:03
Play later
Play later
Lists
Like
Liked
52:03
Dr Matthew Lunning from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on the management of toxicities associated with CAR T-cell therapy. CME information and select publications here.
…
continue reading
1
Analysis of IELSG37 Trial Results and PF4 in Stem Cell Aging
16:14
16:14
Play later
Play later
Lists
Like
Liked
16:14
In this week's episode, Blood editor Dr. James Griffin speaks with Drs. Emanuele Zucca and Sandra Pinho about their latest articles published in Blood. Dr. Zucca discusses his second analysis of the IELSG37 trial, where findings suggested that R-CHOP21 rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, administered every 21 days…
…
continue reading
1
025 An Additional New Hope - Understanding GPRC5D Treatment
33:19
33:19
Play later
Play later
Lists
Like
Liked
33:19
This episode introduces Talquetamab - a newly approved bispecific antibody for relapsed myeloma - explaining how it works, who it’s for, and what side effects patients should expect and prepare for. 📌Key Takeaways: Talquetamab is a brand-new treatment targeting GPRC5D - offering another effective option after several previous therapies. Early side …
…
continue reading
1
EM Quick Hits 69 Pediatric Urinary Retention & Acute Transverse Myelitis, Post-Dural Puncture Headache, Med Mal Cases: Clenched Fist Injury, IV Thrombolysis for Minor Stroke, EM Leadership Spotlight #4 ...
1:32:19
1:32:19
Play later
Play later
Lists
Like
Liked
1:32:19
On this month's EM Quick Hits podcast: Deborah Schonfeld on the differential diagnosis and work up of pediatric urinary retention & acute transverse myelitis, Jesse McLaren on his Tryptic Approach to Occlusion MI Diagnosis, Matthew McArthur on recognition and management of post-dural puncture headache, Joseph Yasmeh on Med Mal Cases: Clenched fist …
…
continue reading
1
Mahdi Sheikh on pharmaceutical opioid use and subsequent cancer risk
21:42
21:42
Play later
Play later
Lists
Like
Liked
21:42
Mahdi Sheikh joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that regular use of pharmaceutical opioids for pain management may be associated with a higher risk of developing certain cancers, particularly those already known to be linked to opium consumption. Read the full article: https://www.thelancet.com/jour…
…
continue reading
1
Navigating the Toughest Challenges in Hematology Nursing: Insights from HNHCP Leaders
19:07
19:07
Play later
Play later
Lists
Like
Liked
19:07
Join us for this inspiring interview with Erik Aerts from University Hospital Zurich in Switzerland and Mairéad Ní Chonghaile from St. James’s Hospital in Ireland who discuss their extensive work within the Hematology Nurses & Healthcare Professionals Group (HNHCP). Erik, the President, and Mairéad, the Vice-President of HNHCP, describe their unwav…
…
continue reading
1
Fixed-Duration Epcoritamab Combination Therapy for Relapsed or Refractory Follicular Lymphoma and Pre-Transplant Strategies for GVHD post-HSCT
22:01
22:01
Play later
Play later
Lists
Like
Liked
22:01
In this week's episode, Blood editor Dr. Laurie Sehn interviews authors Drs. Lorenzo Falchi and Robert Levy on their latest papers published in Blood Journal. Dr. Falchi discusses his work on an open-label, multicenter phase 1b/2 study evaluating fixed-duration epcoritamab with rituximab and lenalidomide in 108 patients with relapsed or refractory …
…
continue reading
1
Patient and Physician Perspectives on Prostate Cancer Data Presented at ASCO 2025: A Podcast
33:02
33:02
Play later
Play later
Lists
Like
Liked
33:02
In this plain language podcast, highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting 2025 are discussed. These insights come from the perspective of an expert patient and physician, both of whom have experience and expertise in the field of prostate cancer. This podcast is intended to broaden the reach of complex data and…
…
continue reading
1
S1 Ep189: Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology
51:46
51:46
Play later
Play later
Lists
Like
Liked
51:46
In a collaborative podcast with the American Psychosocial Oncology Society hosted by Daniel C. McFarland, DO, guests Louis P. Voigt, MD, and Yesne Alici, MD, discussed the ethical and clinical complexities of assessing decision-making capacity (DMC) in oncology, emphasizing its role as the ethical core of person-centered care. The discussion began …
…
continue reading
1
Bronchiectasis Treatment Goals, Unmet Needs, and Emerging Therapies: A Podcast
30:06
30:06
Play later
Play later
Lists
Like
Liked
30:06
This podcast is published open access in Pulmonary Therapy and is fully citeable. You can access the original published podcast article through the Pulmonary Therapy website and by using this link: https://link.springer.com/article/10.1007/s41030-025-00330-1. All conflicts of interest can be found online. This podcast is intended for medical profes…
…
continue reading
1
Real-World Perspectives on Switching Patients With Multiple Sclerosis From Anti-CD20 Therapy to Cladribine Tablets From
34:28
34:28
Play later
Play later
Lists
Like
Liked
34:28
This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the XX website and by using this link: https://link.springer.com/article/10.1007/s12325-025-03391-5. All conflicts of interest can be found online. This podcast is intended for medical professionals.Open …
…
continue reading
1
Treatment in R/M-SCCHN in the Year 2025 - Standard and Considerations for am Individualized Treatment
47:10
47:10
Play later
Play later
Lists
Like
Liked
47:10
A Podcast Discussion on Medical Treatment in R/M-SCCHN in the Year 2025—Standard and Considerations for an Individualized Treatment A Podcast Discussion on Medical Treatment in R/M-SCCHN in the Year 2025—Standard and Considerations for an Individualized Treatment In this podcast, speakers Dr Konrad Klinghammer and Dr Philipp Ivanyi discuss the gene…
…
continue reading
1
Advancing Blood Disorder Treatments Through Precision Therapeutics
15:08
15:08
Play later
Play later
Lists
Like
Liked
15:08
In this week's episode, Blood editor Dr. Laura Michaelis interviews authors Drs. Terri Parker and Peter Lenting on their latest papers published in Blood Journal. Dr. Lenting discusses his work on introducing a new therapeutic approach to von Willebrand disease with the development of a novel bispecific antibody (KB-V13A12) that links endogenous mo…
…
continue reading
1
024 From Braces to Bone Regrowth: Modern Spine Care in Myeloma
52:55
52:55
Play later
Play later
Lists
Like
Liked
52:55
Sean Molloy, renown spinal surgeon at the Royal National Orthopaedic Hospital (RNOH) NHS Trust in Stanmore explains how tailored bracing, breakthrough bone healing in myeloma, physiotherapy and minimally invasive vertebroplasty can transform pain, mobility and long-term spinal stability. 📌Key Takeaways: A brace can act like “nature’s own surgery”, …
…
continue reading
1
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today?
20:37
20:37
Play later
Play later
Lists
Like
Liked
20:37
In this episode, Benjamin Levy, MD, FASCO, and Alex Spira, MD, PhD, FASCO, discuss the latest developments in targeting TROP2 and TIGIT for the treatment of lung cancer, including: TROP2-targeting ADCs: datopotamab deruxtecan, sacituzumab govitecan, sacituzumab tirumotecan TROP2 ADCS for patients with EGFR-mutated NSCLC TIGIT-targeting agents: domv…
…
continue reading
1
Motivating Fundraisers With Purposeful Recognition with the University of Texas MD Anderson Cancer Center's Meredith Perkins
27:11
27:11
Play later
Play later
Lists
Like
Liked
27:11
Recognition is no longer just about t-shirts or medals - it’s about meaning. Thoughtful, mission-driven recognition strategies can deepen fundraisers’ emotional connection and inspire long-term loyalty. In this episode, Marcie Maxwell talks with Meredith Perkins, Director of Peer-to-Peer Fundraising at The University of Texas MD Anderson Cancer Cen…
…
continue reading
1
S1 Ep188: How Can Chlorotoxin-Directed CAR T-Cell Therapy Impact Glioblastoma Care?
12:42
12:42
Play later
Play later
Lists
Like
Liked
12:42
In a conversation with CancerNetwork®, Michael Barish, PhD, spoke about an investigational CAR T-cell therapy that he and colleagues are developing as a treatment for patients with glioblastoma. He and his team designed the agent to harness chlorotoxin, an amino acid peptide toxin component of scorpion venom, as a vehicle for intratumoral delivery …
…
continue reading
1
Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
59:42
59:42
Play later
Play later
Lists
Like
Liked
59:42
Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Manali Kamdar from the University of Colorado Cancer Center in Aurora discuss patient questions and experiences with CAR T-cell therapy for non-Hodgkin lymphoma. Educational information and select publications here.
…
continue reading
1
Young Hematologists in the Spotlight: EHA2025 Young EHA Award (Dr Mandy Lauw)
22:17
22:17
Play later
Play later
Lists
Like
Liked
22:17
Join us for this interview with Dr Mandy Lauw from Erasmus Medical Center in Rotterdam, Netherlands who describes her work to increase the visibility and voice of young hematologists within the EHA. For her unwavering efforts to improve the support and opportunities for young hematologists at the beginning of their career, Dr Lauw has been awarded …
…
continue reading
1
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
1:00:13
1:00:13
Play later
Play later
Lists
Like
Liked
1:00:13
Dr Matthew Lunning and Dr Sonali M Smith share their perspectives on the evolving therapeutic landscape for patients with diffuse large B-cell lymphoma and follicular lymphoma. CME information and select publications here.
…
continue reading
1
New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials
18:36
18:36
Play later
Play later
Lists
Like
Liked
18:36
In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA could act as a first hit in lung injury, while Dr. Al-Sawaf revealed …
…
continue reading
1
Ep 209 Nondisabling Stroke Recognition and Management
1:19:30
1:19:30
Play later
Play later
Lists
Like
Liked
1:19:30
In this Part 2 or our 2-part podcast update on ED stroke management with Dr. Katie Lin and Dr. Walter Himmel we explore non-disabling strokes, where symptoms are mild enough that patients can continue daily activities if deficits persist. Yet, non-disabling does not mean benign. Non-disabling strokes occupy the same ischemic continuum as TIAs and c…
…
continue reading
1
S1 Ep187: How Supportive Care Methods Can Improve Oncology Outcomes
26:03
26:03
Play later
Play later
Lists
Like
Liked
26:03
The latest episode of Oncology On the Go focused on survivorship and supportive care. Stemming from conversations with leading clinicians in the field, the compilation highlights gaps and educational insights into multiple areas. Covering topics like nutrition, oncodermatology, body image, sexual health, and mortality, these conversations explored …
…
continue reading
1
Supporting Hematology Innovation: Outcomes of an EHA Junior Research Grant (with Dr Ferran Nadeu Prat)
19:23
19:23
Play later
Play later
Lists
Like
Liked
19:23
Join us for this interview with Dr Ferran Nadeu Prat from August Pi i Sunyer Biomedical Research Institute in Barcelona, Spain who discusses his work on evolution of chronic lymphocytic leukemia (CLL), which he conducted thanks to the EHA Junior Research Grant. Dr Nadeu Prat explains how the new insights into CLL evolution toward Richter transforma…
…
continue reading
1
A Newly Approved Targeted Combination Therapy for KRAS-Mutant Low-Grade Serous Ovarian Cancer
22:14
22:14
Play later
Play later
Lists
Like
Liked
22:14
In this episode, Dr Rachel Grisham and Dr Kathleen Moore discuss newly approved treatments for low-grade serous ovarian cancer (LGSOC) and how recent research has transformed the therapeutic landscape for these patients, including: Molecular distinctions between low-grade and high-grade serous ovarian cancer that can guide therapy selection The rec…
…
continue reading
1
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
9:36
9:36
Play later
Play later
Lists
Like
Liked
9:36
In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-cell lymphoma in a study with 245 patients. Findings show a tentative wa…
…
continue reading
1
023 Numbness, Tingling and Treatment: Making Sense of Neuropathy
35:30
35:30
Play later
Play later
Lists
Like
Liked
35:30
Dr Jam & Sally unpack what neuropathy is, why it happens in myeloma treatment, and how patients can recognise, prevent and manage it to protect their quality of life. 📌Key Takeaways: Know the signs early – tingling, numbness or pain shouldn’t be ignored; speak up before symptoms worsen. Treatment can be adjusted – modern dosing and combinations mak…
…
continue reading
1
CDH6-Targeting Antibody–Drug Conjugates in Ovarian Cancer: A Promising Treatment Approach
26:01
26:01
Play later
Play later
Lists
Like
Liked
26:01
In this episode, Kathleen N. Moore, MD, MS, FASCO, and Isabelle Ray-Coquard, MD, PhD, discuss the emerging role of CDH6-targeting antibody–drug conjugates (ADCs) for ovarian cancer, including: Results of the phase I trial of raludotatug deruxtecan (R-DXd) in ovarian cancer Results of the phase II REJOICE-Ovarian01 study in patients with platinum-re…
…
continue reading
1
Balancing National Consistency & Local Flavor in P2P Events with Susan G. Komen’s Andi Hughes
27:48
27:48
Play later
Play later
Lists
Like
Liked
27:48
Many large nonprofits struggle with the tension between standardization and localization in their fundraising programs. When national organizations move toward centralized models, they risk losing the authentic community relationships that make peer-to-peer events successful. Yet operating entirely through local structures can create inefficiencies…
…
continue reading
1
S1 Ep186: How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
29:03
29:03
Play later
Play later
Lists
Like
Liked
29:03
Following a fruitful European Society of Medical Oncology (ESMO) Congress 2025 for gastrointestinal malignancies, CancerNetwork® organized an X Spaces discussion hosted by 3 experts. They were Nicholas J. Hornstein, MD, an assistant professor at the Donald and Barbara Zucker School of Medicine of Hofstra University and Northwell Health; Timothy Bro…
…
continue reading
1
Living with Eosinophilic Granulomatosis with Polyangiitis (EGPA): Podcast of a Patient-Physician Discussion
31:42
31:42
Play later
Play later
Lists
Like
Liked
31:42
Living with Eosinophilic Granulomatosis with Polyangiitis (EGPA): Podcast of a Patient-Physician DiscussionThis podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007…
…
continue reading
1
Transforming Care in Cutaneous Squamous Cell Carcinoma: Integrating Immunotherapy Into Patient Care
35:16
35:16
Play later
Play later
Lists
Like
Liked
35:16
In this podcast, Dr David Miller, MD, PhD, FAAD and Dr Vishal Patel, MD discuss the evolving treatment landscape and immunotherapeutic strategies for cutaneous squamous cell carcinoma (cSCC) based on key data from pivotal studies that are reshaping standards of care, including: Trials of neoadjuvant immunotherapies demonstrating remarkable response…
…
continue reading
1
Ethical Considerations in Gene Therapy for Sickle Cell Disease and Thalassemia (with Prof Mariane de Montalembert)
24:36
24:36
Play later
Play later
Lists
Like
Liked
24:36
Join us for this conversation with prof. Mariane de Montalembert from Necker-Enfants Malades Hospital in France who discusses the current standards of care for patients with sickle cell disease and thalassemia, both in Europe and in sub-Saharan Africa. Prof. de Montalembert highlights the inequalities and the unique challenges in implementation of …
…
continue reading
In this Review Series episode, Associate Editor Dr. Philippe Armand speaks with multiple authors about what it might look like to improve treatments follicular lymphoma, a disease that has been put on the backburner of innovation due to its generally treatable nature. Dr. Armand discusses "Treatment of relapsed and refractory follicular lymphoma: w…
…
continue reading
1
Ep 208 Paradigm Shift in Ischemic Stroke Management Part 1: Disabling Strokes
1:36:12
1:36:12
Play later
Play later
Lists
Like
Liked
1:36:12
We are amidst a paradigm shift in the emergency management of acute ischemic stroke. The traditional way of categorizing ischemic strokes as 'minor' vs 'major' is no longer relevant to what we do in the ED. It's now about 'disabling' vs 'non-disabling' strokes. And this is no small change. This categorization dictates urgency of ED work-up and trea…
…
continue reading
1
Paroxysmal Nocturnal Hemoglobinuria: Translating Pathobiology Into Modern Clinical Management
27:48
27:48
Play later
Play later
Lists
Like
Liked
27:48
In this educational podcast discussion, Carlos M. De Castro, MD, and David Dingli, MD, PhD, FRCP, FRCPEd, FACP, FRCPath, explore paroxysmal nocturnal hemoglobinuria (PNH). They trace the evolution of treatment from early complement inhibitors to today’s expanding therapeutic options, emphasizing how these advances have transformed patient outcomes …
…
continue reading
1
S1 Ep185: What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
11:31
11:31
Play later
Play later
Lists
Like
Liked
11:31
As part of the European Society for Medical Oncology (ESMO) Congress 2025, CancerNetwork® spoke with a variety of experts about key takeaways from different late-breaking abstracts, oral presentations, and other sessions focused on potential advancements across cancer care. Presenting investigators highlighted updated results from clinical trials e…
…
continue reading
1
Exploring two new, validated disease specific outcome measures to assess severity of Chronic Hand Eczema
29:21
29:21
Play later
Play later
Lists
Like
Liked
29:21
This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link:https://link.springer.com/article/10.1007/s13555-025-01551-7. All conflicts of interest can be found online. This podcast is intended for med…
…
continue reading
1
Point-of-care Tests for Neonatal Screening of Sickle Cell Disease (with Prof Béatrice Gulbis)
24:16
24:16
Play later
Play later
Lists
Like
Liked
24:16
Join us for this inspiring interview with prof Béatrice Gulbis from The Brussels University Hospital in Belgium who discusses her extensive work on implementing neonatal screening for sickle cell disease (SCD) in low-resource countries in Africa. Prof Gulbis has been involved in collaborative projects to implement the testing methods that best fit …
…
continue reading
1
Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA
54:59
54:59
Play later
Play later
Lists
Like
Liked
54:59
Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discusses recent datasets and their implications for the current and future management of acute myeloid leukemia. CME information and select publications here.
…
continue reading
1
Breakthroughs in Multiple Myeloma Treatment and Von Willebrand Disease Mechanisms
24:11
24:11
Play later
Play later
Lists
Like
Liked
24:11
In this week's episode of the Blood Podcast, Associate Editor Dr. James Griffin interviews Drs. Binod Dhakal and Ruben Bierings about their respective papers published in this week's issue of Blood. Dr. Dhakal presents his study on using talquetamab, a bispecific antibody, as a bridging therapy before BCMA-targeted CAR T-cell therapy in multiple my…
…
continue reading
1
Patient and Physician Perspectives on Multiple Myeloma Data Presented at ASCO and EHA 2025: A Podcast
45:25
45:25
Play later
Play later
Lists
Like
Liked
45:25
In this plain language podcast, highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting 2025 are discussed, supplemented with additional reflections from the European Hematology Association (EHA) 2025 Congress. These insights come from the perspective of an expert patient and physician, both of whom have experience and exper…
…
continue reading
1
022 Remission, Relapse and Reality Understanding the R-Words in Myeloma
33:07
33:07
Play later
Play later
Lists
Like
Liked
33:07
Dr Jam & Sally unpack what remission, relapse and refractory disease truly mean for people living with myeloma — and explore how close we are to talking about cure. 📌Key Takeaways: Remission ≠ cure – myeloma can be controlled for years, even if it never fully disappears. Monitoring matters – blood tests, bone marrow checks and scans together tell t…
…
continue reading
1
Onboarding & Coaching A High-Impact Volunteer Team with Four Diamonds' Suzanne Graney
30:09
30:09
Play later
Play later
Lists
Like
Liked
30:09
Managing volunteer leadership presents unique challenges, especially when your entire executive team changes annually. The most successful campaigns don't just recruit great volunteers—they systematically develop them into unified, mission-driven teams that can execute at the highest level despite constant turnover. In this episode, Marcie Maxwell …
…
continue reading
1
S1 Ep184: Leveraging Biology to Advance the Small Cell Lung Cancer Treatment Paradigm
13:12
13:12
Play later
Play later
Lists
Like
Liked
13:12
In a discussion with CancerNetwork®, Anne Chiang, MD, PhD, spoke about the current treatment landscape for those with small cell lung cancer (SCLC) as well as next steps for elevating the quality of care among patients. She began by outlining the evolution of therapeutic standards in the field, with atezolizumab (Tecentriq)- and durvalumab (Imfinzi…
…
continue reading
